Skip to main content
CHRS logo

CHRS · Coherus Oncology, Inc. · Held by Funds

Track CHRS — free
$0.37 -0.02 (-4.47%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$57.15M
Shares
154.54M
Volume · Nov 20 2.52M Avg daily vol (3M) 1.8M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of CHRS by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 10.85% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.79% 4,318,982
Index ETFs 8.05% 12,447,929
Active ETFs 0.01% 19,591
Active funds 2.03% 3,137,943
Unclassified 0.01% 14,072
All registered funds 12.90% 19,938,517
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding CHRS

126 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 126 positions
Key facts CIK 1512762 CUSIP 19249H103 13F (30d) 150 filings 120 filers Visit website Investor relations